Cleerly LABS vs DeepRhythmAI
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if your primary need is a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to precisely quantify atherosclerosis, characterize plaque, and detect stenosis. This tool is ideal for clinicians focused on personalized heart disease management, risk stratification, and tracking the progression of coronary artery disease through detailed anatomical imaging.
View Cleerly LABS →Choose DeepRhythmAI if…
Choose DeepRhythmAI if your focus is on revolutionizing cardiac arrhythmia detection and classification from ECG data with superior accuracy and efficiency. This AI algorithm is best suited for healthcare providers seeking to streamline ECG reporting, reduce missed diagnoses of arrhythmias, and integrate device-agnostic, cloud-based analysis into their clinical workflows.
View DeepRhythmAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | DeepRhythmAI |
|---|---|---|
| Pricing | Varies | Contact vendor for pricing information |
| Deployment | Cloud, On-premise | Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cleerly LABSCleerly LABS (Tool A) is described as a web-based application with '3D visualization of coronary arteries' and integration with PACS, RIS, and EHR. This suggests a highly interactive and visually rich user experience for complex image analysis. DeepRhythmAI (Tool B) focuses more on backend processing efficiency for ECG data, without specific mentions of advanced visualization or interactive features for end-users.
Clinical Value
DeepRhythmAIBoth tools offer significant clinical value and are FDA-cleared. However, DeepRhythmAI (Tool B) provides a highly quantifiable and impactful clinical outcome, claiming to reduce missed diagnoses by '14x to 114x fewer' and being trained on '250 billion+ annotated heartbeats'. While Cleerly LABS (Tool A) offers comprehensive plaque assessment and personalized risk, the direct and substantial improvement in diagnostic accuracy stated by Tool B is a stronger indicator of immediate clinical impact.
Pricing & Value
Cleerly LABSCleerly LABS (Tool A) offers transparent pricing, detailing a retail price of $1500, a discounted rate of $750, and acknowledging potential out-of-pocket costs. DeepRhythmAI (Tool B) only states 'enterprise' pricing with 'Unknown' details, making it impossible to assess its value proposition without further information. Therefore, Tool A wins on pricing transparency.
Enterprise Readiness
Cleerly LABSBoth tools demonstrate strong enterprise readiness. Cleerly LABS (Tool A) explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), along with cloud deployment (AWS) and integration with PACS, RIS, and EHR via an on-site proxy. DeepRhythmAI (Tool B) also offers cloud deployment, API availability, and targets various health systems, but Tool A's explicit mention of BAA and HIPAA compliance provides a clearer advantage for US healthcare enterprises.
Innovation
DeepRhythmAIBoth tools are innovative in their respective domains. DeepRhythmAI (Tool B) stands out for its advanced AI models (CNN and Transformer) trained on an exceptionally large dataset of '250 billion+ annotated heartbeats' for arrhythmia detection. This massive scale of data and sophisticated model architecture represents a significant technological innovation. Cleerly LABS (Tool A) offers innovative comprehensive CCTA analysis and personalized risk assessment, but the sheer scale of Tool B's training data and model complexity is particularly noteworthy.
Support & Docs
Cleerly LABSCleerly LABS (Tool A) provides a clearly articulated support structure, including dedicated 'Client Support,' 'Patient Support,' and 'Provider Support' channels, with specified operating hours (Monday-Friday, 10 am ET to 6 pm ET) and IT integration assistance. While Medicalgorithmics (Tool B) offers general contact information, a technical support email, and a ticketing system, Tool A's detailed and segmented support options suggest a more comprehensive and accessible support ecosystem.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | DeepRhythmAI |
|---|---|---|
| Name | Cleerly LABS | DeepRhythmAI |
| Company | Cleerly | Medicalgorithmics S.A. |
| Description | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | FDA-cleared, cloud-based AI algorithm that revolutionizes cardiac arrhythmia detection and classification from ECG data, offering superior accuracy and efficiency for physicians. |
| Primary Data Input | Coronary CT angiography (CCTA) | ECG data |
| Key Features (Examples) | AI-powered CCTA image analysis, Comprehensive coronary plaque assessment, Stenosis detection and quantification | AI-powered arrhythmia detection and classification, Utilizes CNN and Transformer models, Trained on 250 billion+ annotated heartbeats |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and DeepRhythmAI.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or DeepRhythmAI
Backers
Who funded each tool's parent company.